PET scans may help guide chemo for rare abdominal cancer
NCT ID NCT04224948
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether PET scans can detect early response to chemotherapy in people with retroperitoneal sarcoma, a rare cancer in the abdomen. 18 participants received extra PET scans before and after their first chemo cycle. The goal was to see if PET could predict tumor shrinkage better than standard CT scans, which take longer to show results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PET MRI scan
What this could lead to
If PET scans prove reliable, doctors could adjust chemotherapy earlier for sarcoma patients, potentially improving outcomes.
What could go wrong
This is a very small, early study (18 people) focused on imaging accuracy, not treatment. It may not change practice or benefit patients directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETROPERITONEAL SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Health Network and The Sinai Health System
Toronto, Ontario, M5G 1X5, Canada